An interventional study of Control Group (A): and Instrument-Assisted Soft Tissue Mobilization (IASTM) in Myofascial Pain Syndrome, sponsored by University of Lahore. Active, not recruiting at 1 site in Pakistan. Open to female participants aged 18 Years to 35 Years. Per ClinicalTrials.gov, last updated 2026-10-29.
Sponsored by University of Lahore · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 32 studies in Myofascial Pain Syndromes with a site in Pakistan — 10 open to participants now, 12 under way, none of them phase 3. Myofascial Pain Syndromes · Pakistan.
Among the 32 studies in Myofascial Pain Syndromes with a site in Pakistan, this one is the 6th largest by enrollment, is one of 7 that started in 2026, is one of 32 with no phase, reaches primary completion later than 9 of the 11 other live ones, and was the 32nd registered.
339 studies on the registry are indexed under Myofascial Pain Syndromes; 66 are open to participants now.
Browse Myofascial Pain Syndromes studies →10 of the 32 studies in Myofascial Pain Syndromes with a site in Pakistan are open now. Recruiting first, the newest first:
Foundation University Islamabad · Sites in Pakistan
Ages 18–35
Riphah International University · Sites in Pakistan
Ages 18–35
Foundation University Islamabad · Sites in Pakistan
Ages 18–25
University of Faisalabad · Sites in Pakistan
Ages 18–30 · Women only
National Orthopedic and General Hospital · Sites in Pakistan
Ages 20–40
A study can be open while its sites in Pakistan have not opened yet or have stopped. Only those recruiting at a site in Pakistan →
Of the 34 Myofascial Pain Syndromes studies recruiting now, 5 (15%) set no upper age limit and 26 (76%) stop at 75 or younger; 2 take children under 18; 4 take healthy volunteers.
This study: 18 Years to 35 Years · female · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
32 studies; the count open now beside each. This study's row is marked.
First in 2018; this study’s year is marked. 7 started in 2026.
This study's enrollment of 60 is above the median of 50 across 307 interventional studies indexed under Myofascial Pain Syndromes.
Median enrollment 37 across the 32 interventional studies. Of the 19 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 32 has an industry lead sponsor. The 10 most frequent:
University of Lahore is the lead sponsor of 234 studies on the registry; 43 are open to participants now.
University of Lahore has 3 studies filed under Myofascial Pain Syndromes — fewer than ten, so there is no comparison to draw.
3 of the studies in Myofascial Pain Syndromes with a site in Pakistan that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07904559University of LahoreComparing Instrument-Assisted Soft Tissue Mobilization and Muscle Energy Technique for Myofascial Pain Syndrome in Women | 2026-12 |
| NCT07573527Riphah International UniversityEffectiveness of Tele-Rehabilitation in Managing Rhomboid Trigger Points in Patients With Myofascial Pain Syndrome | 2026-12 |
| NCT07838584Foundation University IslamabadComparison of Ischemic Release and Sustained Pressure Direct Myofascial Release in Upper Trapezius Trigger Point | 2026-12-18 |
Add all 3 to your calendar (.ics) → With an account.
Among the 32 studies in Myofascial Pain Syndromes with a site in Pakistan, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study compares Instrument-Assisted Soft Tissue Mobilization (IASTM) and Muscle Energy Technique (MET) in female patients with myofascial pain syndrome. The study aims to evaluate the effects of both techniques on pain and related clinical outcomes to determine their effectiveness in managing the condition.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Patients diagnosed with myofascial pain syndrome.
Patients experiencing localized muscle pain and tenderness.
Patients willing to participate in the study and provide .
Patients able to follow the treatment protocol and complete the required assessments.
Exclusion Criteria:
Patients with fractures or recent surgery in the affected area.
Patients with neurological disorders affecting the study area.
Patients with to Instrument-Assisted Soft Tissue Mobilization (IASTM) or Muscle Energy Technique (MET).
Patients unwilling to participate or unable to complete the study protocol.
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants in the control group will receive the control intervention described in the study protocol.
Other: Control Group (A): · Procedure: Instrument-Assisted Soft Tissue Mobilization (IASTM) · Other: Muscle Energy Technique (MET)
Participants will receive Instrument-Assisted Soft Tissue Mobilization (IASTM) for the management of myofascial pain syndrome.
Other: Control Group (A): · Procedure: Instrument-Assisted Soft Tissue Mobilization (IASTM) · Other: Muscle Energy Technique (MET)
Participants will receive Muscle Energy Technique (MET) for the management of myofascial pain syndrome.
Other: Control Group (A): · Procedure: Instrument-Assisted Soft Tissue Mobilization (IASTM) · Other: Muscle Energy Technique (MET)
Participants will receive the control intervention as specified in the study protocol.
Participants will receive Instrument-Assisted Soft Tissue Mobilization (IASTM), a physiotherapy technique used to address soft tissue restrictions and manage pain associated with myofascial pain syndrome.
Participants will receive Muscle Energy Technique (MET), a manual therapy technique involving controlled muscle contractions to help improve muscle flexibility and reduce pain associated with myofascial pain syndrome.
Pain Intensity Measured by the Numeric Pain Rating Scale (NPRS)
Pain intensity will be assessed using the Numeric Pain Rating Scale (NPRS), an 11-point scale ranging from 0 (no pain) to 10 (worst imaginable pain). Scores will be recorded before and after the intervention to evaluate changes in pain intensity.
Time frame: Baseline (before intervention) to immediately after completion of the intervention period.
Started Oct 2026 (actual). Primary completion is estimated for Dec 2026, 2 months after the start.
Of 202 non-industry interventional studies with no phase under Myofascial Pain Syndromes, half reached primary completion within 5 months of starting (the median), counting those still running; a quarter within 2 and three quarters within 12. This study's planned 2 months is below that.
Counting every sponsor, half of 204 studies reached it within 5 months; a quarter within 2 and three quarters within 13.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is active, not recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.